NFA
IMMU

Nationwide Fund Advisors’s Immunomedics Inc IMMU Stock Holding History

Nationwide Fund Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-56,912
Closed -$796K – 2639
2017
Q3 		$796K Hold
56,912
– – ﹤0.01% 1929
2017
Q2 		$503K Sell
56,912
-1,140
-2% -$8.01K ﹤0.01% 2183
2017
Q1 		$376K Sell
58,052
-342
-0.6% -$1.73K ﹤0.01% 2302
2016
Q4 		$214K Hold
58,394
– – ﹤0.01% 2570
2016
Q3 		$190K Hold
58,394
– – ﹤0.01% 2651
2016
Q2 		$135K Sell
58,394
-6,091
-9% -$20.4K ﹤0.01% 2796
2016
Q1 		$161K Hold
64,485
– – ﹤0.01% 2628
2015
Q4 		$198K Buy
64,485
+2,264
+4% +$6.32K ﹤0.01% 2560
2015
Q3 		$107K Hold
62,221
– – ﹤0.01% 2875
2015
Q2 		$253K Buy
62,221
+2,219
+4% +$9.07K ﹤0.01% 2584
2015
Q1 		$230K Sell
60,002
-3,171
-5% -$13.8K ﹤0.01% 2623
2014
Q4 		$303K Sell
63,173
-696
-1% -$2.75K ﹤0.01% 2449
2014
Q3 		$238K Buy
63,869
+624
+1% +$2.11K ﹤0.01% 2606
2014
Q2 		$231K Buy
63,245
+6,904
+12% +$25.3K ﹤0.01% 2680
2014
Q1 		$237K Sell
56,341
-701
-1% -$3.48K ﹤0.01% 2413
2013
Q4 		$262K Sell
57,042
-11,355
-17% -$50.6K ﹤0.01% 2559
2013
Q3 		$423K Buy
68,397
+13,654
+25% +$78.6K ﹤0.01% 2308
2013
Q2 		$298K Buy
+54,743
New +$180K ﹤0.01% 2301

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nationwide Fund Advisors's IMMU Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Immunomedics Inc (IMMU) in Q4 2017, closing a stake of 56,912 shares — an estimated $796K sold.

Nationwide Fund Advisors first reported a position in IMMU in Q2 2013 and held it in 18 quarters. The position peaked at $796K in Q3 2017. 157 funds tracked by Wall St. Rank hold IMMU as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Immunomedics Inc position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 56,912 Immunomedics Inc shares in Q4 2017, an estimated $796K.
  • Nationwide Fund Advisors first reported a position in Immunomedics Inc in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Immunomedics Inc position peaked at $796K in Q3 2017.
  • 157 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.